Treco Douglas A

CEO & Chairman at Inozyme Pharma, Inc.

Sold, on record
$60k
Dollars the filings state
Form 4 sales
2
Latest Apr 2, 2025
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Inozyme Pharma, Inc.Unusual
    Apr 2, 2024 2024

    Sold 7,523 shares at $6.94 ($52k)

    Treco Douglas A, CEO

    No 10b5-1 planSold 26.7% of holdings ($196k position)20,665 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Inozyme Pharma, Inc.No plan
    Apr 2, 2025 +365 days

    Sold 8,819 shares at $0.89 ($8k)

    Treco Douglas A, CEO & Chairman

    No 10b5-1 planSold 17.7% of holdings ($44k position)41,046 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Treco Douglas A
Source
Apr 2, 2025Apr 3, 2025Inozyme Pharma, Inc.CEO & ChairmanForm 4 sale8,819$8k17.7%No planSEC
Apr 2, 2024Apr 3, 2024Inozyme Pharma, Inc.CEOForm 4 sale7,523$52k26.7%UnusualSEC